Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

December 01, 1999; Volume 27,Issue 12

Articles

  • You have access
    Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ × APN F2 Mice
    William L. Casley, J. Allan Menzies, Larry W. Whitehouse and Thomas W. Moon
    Drug Metabolism and Disposition December 1999, 27 (12) 1375-1380;
  • You have access
    Azelastine N-Demethylation by Cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in Human Liver Microsomes: Evaluation of Approach to Predict the Contribution of Multiple CYPs
    Miki Nakajima, Sumika Nakamura, Shogo Tokudome, Noriaki Shimada, Hiroshi Yamazaki and Tsuyoshi Yokoi
    Drug Metabolism and Disposition December 1999, 27 (12) 1381-1391;
  • You have access
    Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen
    Masahiko Kawai, Stelvio M. Bandiera, Thomas K. H. Chang, Frederique M. Poulet, Paul M. Vancutsem and Gail D. Bellward
    Drug Metabolism and Disposition December 1999, 27 (12) 1392-1398;
  • You have access
    Enhancement of Platinum-Drug Cytotoxicity in a Human Head and Neck Squamous Cell Carcinoma Line and its Platinum-Resistant Variant by Liposomal Amphotericin B and Phospholipase A2-II
    Peter J. Ferguson, Catherine Currie and Mark D. Vincent
    Drug Metabolism and Disposition December 1999, 27 (12) 1399-1405;
  • You have access
    Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat
    Kenji Matsui, Mannen Mishima, Yasushi Nagai, Teruaki Yuzuriha and Tsutomu Yoshimura
    Drug Metabolism and Disposition December 1999, 27 (12) 1406-1414;
  • You have access
    Drug Metabolizing Capacity of Cryopreserved Human, Rat, and Mouse Liver Parenchymal Cells in Suspension
    Pablo Steinberg, Thomas Fischer, Sandra Kiulies, Katja Biefang, Karl-Ludwig Platt, Franz Oesch, Thomas Böttger, Clemens Bulitta, Peter Kempf and Jan Hengstler
    Drug Metabolism and Disposition December 1999, 27 (12) 1415-1422;
  • You have access
    Effect of Selective Phase II Enzyme Inducers on Glucuronidation of Benoxaprofen in Rats
    Jennifer Q. Dong, Amy S. Etheridge and Philip C. Smith
    Drug Metabolism and Disposition December 1999, 27 (12) 1423-1428;
  • You have access
    Role of Human CYP2B6 in S-MephobarbitalN-Demethylation
    Kaoru Kobayashi, Seiji Abe, Miki Nakajima, Noriaki Shimada, Masayoshi Tani, Kan Chiba and Toshinori Yamamoto
    Drug Metabolism and Disposition December 1999, 27 (12) 1429-1433;
  • You have access
    Biotransformation of Nevirapine, a Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor, in Mice, Rats, Rabbits, Dogs, Monkeys, and Chimpanzees
    Paul S. Riska, David P. Joseph, Roger M. Dinallo, Walter C. Davidson, James J. Keirns and Susan E. Hattox
    Drug Metabolism and Disposition December 1999, 27 (12) 1434-1447;
  • You have access
    Residence Times and Half-Lives of Nicotine Metabolites in Rat Brain after Acute Peripheral Administration of [2′-14C]Nicotine
    Omar Ghosheh, Linda P. Dwoskin, Wen-Kui Li and Peter A. Crooks
    Drug Metabolism and Disposition December 1999, 27 (12) 1448-1455;
  • You have access
    Metabolism and Disposition of [14C]1-Nitronaphthalene in Male Sprague-Dawley Rats
    Jason S. Halladay, John-Michael Sauer and I. Glenn Sipes
    Drug Metabolism and Disposition December 1999, 27 (12) 1456-1465;
  • You have access
    Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
    John P. Gibbs, Chris A. Liacouras, Robert N. Baldassano and John T. Slattery
    Drug Metabolism and Disposition December 1999, 27 (12) 1466-1469;
  • You have access
    Toxicokinetics of 1,2-Diethylbenzene in Male Sprague-Dawley Rats—Part 1: Excretion and Metabolism of [14C]1,2-Diethylbenzene
    Jean-Paul Payan, Dominique Beydon, Benoît Cossec, André Ensminger, Jean-Paul Fabry and Elisabeth Ferrari
    Drug Metabolism and Disposition December 1999, 27 (12) 1470-1478;
  • You have access
    A Method for Estimating Pharmacokinetic Risks of Concentration-Dependent Drug Interactions from Preclinical Data
    Murali Ramanathan
    Drug Metabolism and Disposition December 1999, 27 (12) 1479-1487;
  • You have access
    Characterization of the In Vitro Biotransformation of the HIV-1 Reverse Transcriptase Inhibitor Nevirapine by Human Hepatic Cytochromes P-450
    David A. Erickson, Gary Mather, William F. Trager, Rene H. Levy and James J. Keirns
    Drug Metabolism and Disposition December 1999, 27 (12) 1488-1495;
  • You have access
    Pharmacokinetics of Orally Administered Desferrithiocin Analogs in Cebus apella Primates
    Raymond J. Bergeron, William R. Weimar and Jan Wiegand
    Drug Metabolism and Disposition December 1999, 27 (12) 1496-1498;
  • You have access
    Absorption, Metabolism, and Disposition of 1,3-Diphenyl-1-Triazene in Rats and Mice after Oral, i.v., and Dermal Administration
    James M. Mathews and Kristi S. De Costa
    Drug Metabolism and Disposition December 1999, 27 (12) 1499-1504;
  • You have access
    Ethynylestradiol-Mediated Induction of HepaticCYP3A9 in Female Rats: Implication for Cyclosporine Metabolism
    Walter Jäger, Maria Almira Correia, Lester M. Bornheim, Axel Mahnke, Walter G. Hanstein, Linlong Xue and Leslie Z. Benet
    Drug Metabolism and Disposition December 1999, 27 (12) 1505-1511;
  • You have access
    Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs
    Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
    Drug Metabolism and Disposition December 1999, 27 (12) 1512-1518;

Letters to the Editor

  • You have access
    CYP2C9 Is a Principal Low-Affinity Phenacetin O-Deethylase: Fluvoxamine Is Not a Specific CYP1A2 Inhibitor.
    Karthik Venkatakrishnan, Lisa L. von Moltke and David J. Greenblatt
    Drug Metabolism and Disposition December 1999, 27 (12) 1519-1520;
  • You have access
    Response to Letter to the Editor
    Kaoru Kobayashi, Miki Nakajima, Kanako Oshima, Noriaki Shimada, Tsuyoshi Yokoi and Kan Chiba
    Drug Metabolism and Disposition December 1999, 27 (12) 1521-1522;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 27 (12)
Drug Metabolism and Disposition
Vol. 27, Issue 12
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics